Rigel Pharmaceuticals reported $21.54M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Acura Pharmaceuticals ACUR:US 613K 31K
Agenus AGEN:US $ 252.95M 242.22M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Amgen AMGN:US $ 6706M 180M
Anika Therapeutics ANIK:US $ 39.54M 1.39M
Applied Genetic Technologies AGTC:US $ 0M 0.5M
Arrowhead Research ARWR:US $ 38.28M 7.61M
Astrazeneca AZN:US $ 9866M 1646M
AstraZeneca AZN:LN 9866M 1646M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Bristol Myers Squibb BMY:US $ 11624M 79M
Celldex Therapeutics CLDX:US $ 0.15M 3.33M
Chemocentryx CCXI:US $ 17.74M 15.93M
Daiichi Sankyo 4568:JP Y 265896M 1827M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Halozyme Therapeutics HALO:US $ 115.83M 20.62M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Immunogen IMGN:US $ 9.21M 7.74M
Intrexon XON:US $ 21.56M 12.02M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Ligand Pharmaceuticals LGND:US $ 64.83M 19.84M
Macrogenics MGNX:US $ 15.66M 15.1M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Pfizer PFE:US $ 24094M 5117M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Rigel Pharmaceuticals RIGL:US $ 21.54M 4.72M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M
Veracyte VCYT:US $ 60.37M 5.26M